Patents by Inventor Nancy J. Sullivan

Nancy J. Sullivan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200149069
    Abstract: This invention provides vaccines for inducing an immune response and protection against filovirus infection for use as a preventative vaccine in humans. In particular, the invention provides chimpanzee adenoviral vectors expressing filovirus proteins from different strains of Ebolavirus (EBOV) or Marburg virus (MARV).
    Type: Application
    Filed: January 24, 2020
    Publication date: May 14, 2020
    Applicants: The Government of the United States of America as Represented by the Secretary of the Department of, GlaxoSmithKline Biologicals SA
    Inventors: Nancy J. Sullivan, Gary J. Nabel, Clement Asiedu, Cheng Cheng, Alfredo Nicosia, Riccardo Cortese, Virginia Ammendola, Stefano Colloca
  • Patent number: 10584355
    Abstract: This invention provides vaccines for inducing an immune response and protection against filovirus infection for use as a preventative vaccine in humans. In particular, the invention provides chimpanzee adenoviral vectors expressing filovirus proteins from different strains of Ebolavirus (EBOV) or Marburg virus (MARV).
    Type: Grant
    Filed: October 31, 2016
    Date of Patent: March 10, 2020
    Assignees: THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Nancy J. Sullivan, Gary J Nabel, Clement Asiedu, Cheng Cheng, Alfredo Nicosia, Riccardo Cortese, Virginia Ammendola, Stefano Colloca
  • Patent number: 9701718
    Abstract: Provided are recombinant adenovirus vectors (serotype 26 and serotype 35) encoding filovirus antigens. The adenovirus vectors can be used to induce protective immune responses against filovirus infection.
    Type: Grant
    Filed: December 14, 2011
    Date of Patent: July 11, 2017
    Assignees: Janssen Vaccines & Prevention B.V., THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, THE OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTE OF HEALTH
    Inventors: Nancy J. Sullivan, Gary J. Nabel, Clement Asiedu, Cheng Cheng, Maria Grazia Pau, Jaap Goudsmit
  • Publication number: 20170044571
    Abstract: This invention provides vaccines for inducing an immune response and protection against filovirus infection for use as a preventative vaccine in humans. In particular, the invention provides chimpanzee adenoviral vectors expressing filovirus proteins from different strains of Ebolavirus (EBOV) or Marburg virus (MARV).
    Type: Application
    Filed: October 31, 2016
    Publication date: February 16, 2017
    Inventors: Nancy J. Sullivan, Gary J Nabel, Clement Asiedu, Cheng Cheng, Alfredo Nicosia, Riccardo Cortese, Virginia Ammendola, Stefano Colloca
  • Patent number: 9526777
    Abstract: This invention provides vaccines for inducing an immune response and protection against filovirus infection for use as a preventative vaccine in humans. In particular, the invention provides chimpanzee adenoviral vectors expressing filovirus proteins from different strains of Ebola virus (EBOV) or Marburg virus (MARV).
    Type: Grant
    Filed: April 15, 2011
    Date of Patent: December 27, 2016
    Assignees: The United States of America as Represented by the Department of Health and Human Services, Glaxosmithkline Biologicals SA
    Inventors: Nancy J. Sullivan, Gary J. Nabel, Clement Asiedu, Cheng Cheng, Alfredo Nicosia, Riccardo Cortese, Virginia Ammendola, Stefano Colloca
  • Publication number: 20140017278
    Abstract: Provided are recombinant adenovirus vectors (serotype 26 and serotype 35) encoding filovirus antigens. The adenovirus vectors can be used to induce protective immune responses against filovirus infection.
    Type: Application
    Filed: December 14, 2011
    Publication date: January 16, 2014
    Inventors: Nancy J. Sullivan, Gary J. Nabel, Clement Asiedu, Cheng Cheng, Maria Grazia Pau, Jaap Goudsmit
  • Publication number: 20130101618
    Abstract: This invention provides vaccines for inducing an immune response and protection against filovirus infection for use as a preventative vaccine in humans. In particular, the invention provides chimpanzee adenoviral vectors expressing filovirus proteins from different strains of Ebolavirus (EBOV) or Marburg virus (MARV).
    Type: Application
    Filed: April 15, 2011
    Publication date: April 25, 2013
    Applicants: OKAIROS AG, TheGovernmentof the UnitedStatesof America asRepre -sentedby theSecretaryoftheDept.ofHealth&HumanSer
    Inventors: Nancy J. Sullivan, Gary J. Nabel, Clement Asiedu, Cheng Cheng, Alfredo Nicosia, Riccardo Cortese, Virginia Ammendola, Stefano Colloca
  • Publication number: 20130046560
    Abstract: Some embodiments may be directed to matching users, such as employees, with insurance records in an integrated database, wherein the integrated database includes a plurality of insurance records, each record being associated with a unique employee and having a plurality of fields. According to some embodiments, new employee information may be received and it may be determined that the new employee information does not qualify as a strong match with any insurance record in the integrated database. Moreover, it may be determined, based on a probabilistic pattern match of the new employee information with values in the fields of the integrated database, that the new employee information qualifies as a weak match with a particular insurance record in the integrated database.
    Type: Application
    Filed: August 19, 2011
    Publication date: February 21, 2013
    Inventors: Garry Jean Theus, James L. Pabilonia, Jennifer B. Raibeck, Shawn K. Simpson, Nancy J. Sullivan
  • Patent number: 8080974
    Abstract: The battery charge indicator provides a color-coded battery status indicator system adapted for attachment to or adjacent the battery compartment on a power tool body. The system includes a first member that is adapted for attachment to the surface of the power tool. The front face of the first member is provided with hook and loop fastener material thereon. A second member has a first face fabricated from green-colored hook and loop fastener material and an opposite, second face fabricated from red-colored hook or loop fastener material. Display of the red-colored face indicates that the battery needs recharging. Display of the green-colored face indicates that the battery is charged.
    Type: Grant
    Filed: August 18, 2010
    Date of Patent: December 20, 2011
    Inventors: Nancy J. Sullivan, Robert E. Sullivan
  • Patent number: 8017130
    Abstract: The present invention relates to genetic vaccines for stimulating cellular and humoral immune responses in humans and other hosts, and, in particular, relates to recombinant viruses that express heterologous antigens of pathogenic viruses, in single dose form.
    Type: Grant
    Filed: November 5, 2009
    Date of Patent: September 13, 2011
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Gary J. Nabel, Nancy J. Sullivan, Thomas W. Geisbert, Peter B. Jahrling
  • Publication number: 20110050238
    Abstract: The battery charge indicator provides a color-coded battery status indicator system adapted for attachment to or adjacent the battery compartment on a power tool body. The system includes a first member that is adapted for attachment to the surface of the power tool. The front face of the first member is provided with hook and loop fastener material thereon. A second member has a first face fabricated from green-colored hook and loop fastener material and an opposite, second face fabricated from red-colored hook or loop fastener material. Display of the red-colored face indicates that the battery needs recharging. Display of the green-colored face indicates that the battery is charged.
    Type: Application
    Filed: August 18, 2010
    Publication date: March 3, 2011
    Inventors: NANCY J. SULLIVAN, ROBERT E. SULLIVAN
  • Publication number: 20100047282
    Abstract: The present invention relates to genetic vaccines for stimulating cellular and humoral immune responses in humans and other hosts, and, in particular, relates to recombinant viruses that express heterologous antigens of pathogenic viruses, in single dose form.
    Type: Application
    Filed: November 5, 2009
    Publication date: February 25, 2010
    Applicant: The Government of the USA as represented by the Secretary of Health and Human Services, NIH
    Inventors: Gary J. Nabel, Nancy J. Sullivan, Thomas W. Geisbert, Peter B. Jahrling
  • Patent number: 7635485
    Abstract: The present invention relates to genetic vaccines for stimulating cellular and humoral immune responses in humans and other hosts, and, in particular, relates to recombinant viruses that express heterologous antigens of pathogenic viruses, in single dose form.
    Type: Grant
    Filed: January 17, 2006
    Date of Patent: December 22, 2009
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Gary J. Nabel, Nancy J. Sullivan, Thomas W. Geisbert, Peter B. Jahrling